HLA-matched and HLA-haploidentical allogeneic CD19-directed chimeric antigen receptor T-cell infusions are feasible in relapsed or refractory B-cell acute lymphoblastic leukemia before hematopoietic stem cell transplantation

Authors: Xin Jin, Yaqing Cao, Luqiao Wang, Rui Sun, Lin Cheng, Xiaoyuan He, Xia Xiao, Yili Jiang, Qing Li, Huan Zhang, Wenyi Lu, Cuicui Lyu, Yanyu Jiang, Juanxia Meng, Mingfeng Zhao

Published: 2019-10-18

DOI: 10.1038/s41375-019-0610-x

Source: Full article

---

Abstract

No abstract found.